medigraphic.com
ISSN 0016-3813 (Print)

2017, Number 5

<< Back Next >>

Gac Med Mex 2017; 153 (5)

Utility intervention programs in the evolutional control of patients with heart failure

Flamarique-Pascual Á, Esteban-Zubero E, Ruiz-Ruiz FJ, Ruiz-Laiglesia F

Language: Spanish
References: 27
Page: 590-597
PDF size: 283.74 Kb.


ABSTRACT

Acute heart failure (HF) is a prevalent disease with important socio-economic repercussions. Due to the aging of population, these values will increase in the coming years, so it may be useful to the implementation of intervention programs in these patients to decrease morbidity and mortality. A quasi-experimental prospective study (n = 262) of patients admitted at the Internal Medicine Department of the Hospital Clínico Universitario Lozano Blesa, in Zaragoza, Spain, diagnosed of HF between November 2013 and October 2014 (both dates inclusive) (n = 108) followed up for 1 year was performed. Within this group, a subgroup with an intensive intervention (n = 30) was performed. The data were compared with a historical cohort of patients admitted to the same department during the same time in the previous year (from November 2012 to October 2013) (n = 154). Statistically significant differences between groups attending to the therapeutical adherence to clinical guidelines (p ‹ 0.011) were observed. Considering the intensive intervention subgroup, statistically significant differences were observed in the rate of exitus (p ‹ 0.032) and survival (log rank ‹0.030) compared to the control group. The close monitoring of patients with HF improves adherence, reduces mortality and improves survival. This May result in a decline in the use of health resources, which entails significant socio-economic benefits.


REFERENCES

  1. Llorens P, Miró O, Martín Sánchez FJ, et al. Manejo de la insuficiencia cardiaca aguda en los servicios de urgencias, emergencias y unidades adscritas. Documento de consenso del Grupo de Insuficiencia Cardiaca Aguda de la Sociedad Española de Medicina de Urgencias y Emergencias (ICA-SEMES). Emergencias. 2011;23:119-39.

  2. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.

  3. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages. Application of the American College of Cardiology/American Heart Association Heart Failure staging criteria in the community. Circulation. 2007;115:1563-70.

  4. Roger VL. The heart failure epidemic. Int J Environ Res Public Health. 2010;7:1807-30.

  5. Setoguchi S, Stevenson LW. Hospitalizations in patients with heart failure: who and why. J Am Coll Cardiol. 2009;54:1703-5.

  6. Go AS, Mozaffarian D, Roger VL, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics. 2013 Update. A report from the American Heart Association. Circulation. 2013;127:e6-245.

  7. Chen J, Normand SLT, Wang Y, et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA. 2011;306:1669-78.

  8. Gheorghiade M, Braunwald E. Hospitalizations for heart failure in the United States − a sign of hope. JAMA. 2011;306:1705-6.

  9. Montes-Santiago J, Arévalo Lorido JC, Cerqueiro González JM. Epidemiología de la insuficiencia cardiaca aguda. Med Clin (Barc). 2014;142(Supl 1):3-8.

  10. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Little, Brown & Co; 1994. p. 253-6.

  11. Blecker S, Paul M, Taksler G, et al. Heart failure-associated hospitalizations in the United States. J Am Coll Cardiol. 2013;61:1259-67.

  12. Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63:1123-33.

  13. Klapholz M. Beta-blocker use for the stages of heart failure. Mayo Clin Proc. 2009;84:718-29.

  14. Nakano A, Johnsen SP, Frederiksen BL, et al. Trends in quality of care among patients with incident heart failure in Denmark 2003-2010: a nationwide cohort study. BMC Health Serv Res. 2013;13:391.

  15. Agvall B, Paulsson T, Foldevi M, et al. Resource use and cost implications of implementing a heart failure program for patients with systolic heart failure in Swedish primary health care. Int J Cardiol. 2014;176:731-8.

  16. von Scheidt W, Zugck C, Pauschinger M, et al. Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol. 2014;103:1006-14.

  17. Hole T, Grundtvig M, Gullestad L, et al. Improved quality of life in Norwegian heart failure patients after follow-up in outpatient heart failure clinics: results from the Norwegian Heart Failure Registry. Eur J Heart Fail. 2010;12:1247‑52.

  18. Smeulders ES, van Haastregt JC, Ambergen T, et al. The impact of a self-management group programme on health behaviour and healthcare utilization among congestive heart failure patients. Eur J Heart Fail. 2009;11:609-16.

  19. Agvall B, Alehagen U, Dahlström U. The benefits of using a heart failure management programme in Swedish primary healthcare. Eur J Heart Fail. 2013;15:228-36.

  20. Comín-Colet J, Verdú-Rotellar JM, Vela E, et al. Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56,742 patients. Rev Esp Cardiol. 2014;67 283-93.

  21. Hebert K, Quevedo HC, Gogichaishvili I, et al. Feasibility of a heart failure disease management program in eastern Europe: Tbilisi, Georgia. Circ Heart Fail. 2011;4:763-9.

  22. Wang Y, Tuomilehto J, Jousilahti P, et al. Healthy lifestyle status, antihypertensive treatment and the risk of heart failure among Finnish men and women. J Hypertens. 2013;31 2158-64.

  23. Puig T, Ferrero-Gregori A, Roig E, et al. Prognostic value of body mass index and waist circumference in patients with chronic heart failure (Spanish REDINSCOR Registry). Rev Esp Cardiol. 2014;67:101-6.

  24. Borné Y, Hedblad B, Essén B, et al. Anthropometric measures in relation to risk of heart failure hospitalization: a Swedish population-based cohort study. Eur J Public Health. 2014;24 215-20.

  25. Rod NH, Andersen I, Prescott E. Psychosocial risk factors and heart failure hospitalization: a prospective cohort study. Am J Epidemiol. 2011;174:672-80.

  26. Schmidt S, Hendricks V, Griebenow R, et al. Demographic change and its impact on the health-care budget for heart failure inpatients in Germany during 1995-2025. Herz. 2013;38:862-7.

  27. Sugrue A, Smyth Y, Hennessy S, et al. Temporal trends in hospitalisations for heart failure. Ir Med J. 2015;108:207-9.




2020     |     www.medigraphic.com